Search - tctmd.com

Displaying 101 - 120 of 390

Sort: Relevancy | Date

Presentation TCT 2017

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

Presenter: Patrick W. Serruys, Liansheng Wang, MD

November 01, 2017

Presentation TCT 2017

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

Presenter: Patrick W. Serruys, Konstantinos Voudris

November 01, 2017

Presentation TCT 2017

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

Presenter: Patrick W. Serruys, Ori Ben-Yehuda

November 01, 2017

Presentation TCT 2017

TCT 109: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions Not Revascularized by Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Cosmo Godino, MD

November 01, 2017

Presentation TCT 2017

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

Presenter: Steven R. Bailey, Patrick W. Serruys, Tobias Schmidt, MD

November 01, 2017

Presentation TCT 2017

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Nicolas M. Van Mieghem

November 01, 2017

Presentation TCT 2017

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

Presenter: Steven R. Bailey, Patrick W. Serruys, Angelo Biviano, MD

November 01, 2017

Presentation TCT 2017

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

Presenter: Steven R. Bailey, Patrick W. Serruys, Mohamed Abdel-Wahab

November 01, 2017

Presentation TCT 2017

The Thin-Strut PLLA-Based Arteriosorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

Endogenous Tissue Restoration: Preclinical Investigation With Restorative Pulmonary and Aortic Valves

Presenter: Jeffrey J. Popma, John G. Webb, Patrick W. Serruys

October 31, 2017

Presentation TCT 2017

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day Two

Shelley Wood

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

Presentation TCT 2017

Complex PCI in Triple Vessel Disease: Do the Economics Make Sense?

Presenter: Fernando Alfonso, Patrick W. Serruys, Hemal Gada

October 30, 2017

Presentation TCT 2017

PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes

Presenter: Fernando Alfonso, Patrick W. Serruys, Paul Kurlansky

October 30, 2017

Presentation TCT 2017

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Presenter: Fernando Alfonso, Patrick W. Serruys, Adrian P. Banning

October 30, 2017

Presentation TCT 2017

Do We Have Enough Data to Make PCI vs CABG Decisions in Complex CAD Using FFR?

Presenter: Fernando Alfonso, Patrick W. Serruys, William F. Fearon

October 30, 2017

Presentation TCT 2017

Videotape Welcome and Comments From Alain Cribier

Presenter: Spencer B. King III, Patrick W. Serruys, Martin B. Leon

October 30, 2017

Advertisement

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

TCT 109: Ten-year Clinical Outcome in Patients With Coronary Chronic Total Occlusions Not Revascularized by Percutaneous Coronary Intervention

TCT 108: Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During TAVR

TCT 107: Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes From the SURTAVI Trial

TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials

TCT 105: Clinical Valve Thrombosis After Transcatheter Aortic Valve-in-Valve Implantation for Degenerated Bioprosthetic Valves: Incidence, Characteristics, and Outcomes

The Thin-Strut PLLA-Based Arteriosorb

Mirage: Imaging and Clinical Outcomes With a Circular PLLA Microfiber-Derived BRS

Endogenous Tissue Restoration: Preclinical Investigation With Restorative Pulmonary and Aortic Valves

PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Live From Denver: TCT 2017, Day Two

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Complex PCI in Triple Vessel Disease: Do the Economics Make Sense?

PCI vs. CABG: The Impact of Medication Adherence on Comparative Outcomes

SYNTAX II: Contemporary Outcomes of PCI in 3VD

Do We Have Enough Data to Make PCI vs CABG Decisions in Complex CAD Using FFR?

Videotape Welcome and Comments From Alain Cribier

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content